ResMed CEO Michael J. Farrell disposes of common shares worth $1,129,744.86
RMD•ResMed CEO Michael J. Farrell exercised options for 4,991 shares at $146.34 and sold the same number at a weighted average price of $226.3349 on Oct. 7, leaving him with 479,803 directly held shares.
1. Share transactions
Farrell exercised options for 4,991 ResMed shares at $146.34 on Oct. 7, 2026, and sold 4,991 shares that day at a weighted average price of $226.3349. His directly held stake fell to 479,803 shares.
